Dairy-Free Butter’ Sparks Legal Storm in U.S. Food Sector

The United States dairy industry, led by the American Butter Institute, is demanding regulatory action from the U.S. Food and Drug Administration (FDA) over the use of the term “butter” on plant-based products. This conflict intensified after Country Crock labeled one of its offerings as “dairy-free butter,” raising legal and consumer confusion concerns. The case highlights the broader tension between traditional dairy producers and the expanding plant-based sector.

The American Butter Institute (ABI), headquartered in Washington, D.C., has intensified its challenge against the labeling of plant-based alternatives as “butter.” The institute, which represents the interests of traditional dairy butter producers in the United States, has called on the U.S. Food and Drug Administration (FDA) to enforce federal standards that define butter strictly as a product derived from milk or cream.

The move comes in response to Country Crock’s recent launch of a product marketed as “dairy-free butter,” a labeling choice the ABI deems deceptive. According to ABI’s Executive Director, Christopher Galen, using dairy-specific terminology on non-dairy products misleads consumers and infringes upon long-established food identity regulations. Galen criticized the term “dairy-free butter” as a “total oxymoron,” arguing it unfairly capitalizes on the high-quality perception associated with real dairy butter.

The federal standard of identity for butter—codified in law—explicitly restricts the use of the term to milk-derived products. By allowing plant-based brands to bypass this regulation, the ABI asserts that the FDA risks damaging consumer trust and blurring the lines in food product marketing.

This is not the first time such a conflict has arisen. The National Milk Producers Federation raised similar objections in 2019, highlighting ongoing concerns over the terminology used in plant-based dairy alternatives. As the plant-based industry continues to grow, these labeling battles represent a larger regulatory crossroads.

ABI’s stance underscores the dairy industry’s concern over eroding market share due to plant-based competitors. Galen emphasized that this isn’t just about branding—it’s about truth in labeling and upholding legal definitions to avoid consumer misinformation.

The FDA’s decision on the matter is expected to influence future labeling practices, setting a potential precedent for other dairy terms like “milk,” “yogurt,” and “cheese” when used on plant-based products.